CEO Peter Nilsson to resume his duties on 30 September 2019

(PresseBox) ( Großbettlingen, )
Reference is made to Kitron’s stock exchange notice on 3 January about CEO Peter Nilsson going on medical leave until the end of June 2019 for cancer treatment.

The treatment has progressed according to the plan and is in its final phases.

The medical leave will be extended until the last treatment phase is concluded by the end of September, and Mr. Nilsson is expected to resume his duties as Kitron CEO on 30 September 2019.

CFO Cathrin Nylander will continue in her role as acting CEO.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act, and section 3-4 of the Oslo Stock Exchange continuing obligations for listed companies.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to